Skip to main content
. 2019 Jun 21;8:933. [Version 1] doi: 10.12688/f1000research.19149.1

Table 1. Timeline of interventions and outcomes.

Timeline Medical history and past interventions
No family history of skin cancer
1999: total gastrectomy for gastric adenocarcinoma
Diagnostic testing and interventions
Past Interventions
2013 – 2017
2000: Patient reports onset of nodular skin lesion
2013: Incisional biopsy: BCC
CT scan (23-Jan-2013): high local burden of disease (5.0cm AP diameter), with destructive osteo-muscular infiltration
    -    vismodegib 150mg daily from Feb to Nov-2013
2014: relapse of nodular skin lesion
Excision biopsy (Feb-2014): SCC
Wide surgical excision (22-May-2014): not radical
Adjuvant chemotherapy:
    -    cisplatinum/fluorouracil for 3 cycles, Aug – Sep-2014
    -    radio-chemotherapy with gemcitabine Dec-2014 – Jan-2015
    -    cisplatinum/docetaxel Aug-2016 – Nov-2016
    -    gemcitabine monotherapy for 8 cycles Dec-2016 – Jul-2017
31-Jan-2018 Baseline assessment Immunohistochemistry: low/no PD-L1 expression
CT scan (31-Jan-2018): 6.2cm AP diameter
19-Apr-2018 Initiation of therapy     -    cetuximab initial single dose of 400mg/m2, then 250mg/m2 weekly
6 weeks Reassessment CT scan (28-May-2018): 7.2cm AP diameter
    -    cetuximab 250mg/m2 every two weeks
12 weeks Final outcome CT scan (12-July-2018): 7.0cm AP diameter
    -    cetuximab 250mg/m2 every two weeks

AP, anterior-posterior; BCC, basal cell carcinoma; CT, computerized tomography; SCC, squamous cell carcinoma; PD-L1, programmed cell death ligand-1.